Racial Disparities in Genetic Detection Rates for Inherited Retinal Diseases

Results from this study highlight a lower genetic detection rate for Black patients than for White patients with IRDs. This supports a concern that the current development of IRD therapeutics is highly dependent on the ability to identify the genetic cause of disease. Patients with no known genetic diagnosis may be disadvantaged in terms of prognostication, inheritance counseling, reproductive decision-making, and eligibility for potential therapeutic options, including clinical trials. As future treatments become available, these findings suggest the need to examine the genetic detection rates across majority and minority subgroups alike.

Authors

Institutions

Publication Details

Journal
JAMA Ophthalmology
Published
2024-11-07
DOI
https://doi.org/10.1001/jamaophthalmol.2024.4696
Citations
8
Primary Topic
Retinal Development and Disorders
Type
article
Field-Weighted Citation Impact
1.87
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Racial Disparities in Genetic Detection Rates for Inherited Retinal Diseases

John R. Heckenlively, Rebhi Abuzaitoun, Gabrielle D. Lacy, Thiran Jayasundera et al.
8 citations
JAMA Ophthalmology
Retinal Development and Disorders
1.87
article

Racial Disparities in Genetic Detection Rates for Inherited Retinal Diseases

John R. Heckenlively, Rebhi Abuzaitoun, Gabrielle D. Lacy, Thiran Jayasundera, Dana Schlegel, Chris Andrews, Juha Koskenvuo, Todd A. Durham, Sari Tuupanen, Abigail T. Fahim, Peter Y. Zhao, David C. Musch, Meenakshi Kumar, Kari Branham, Maria Fernanda Abalem, Robert B. Hufnagel, Naheed W. Khan
article en
8 citations

Abstract

Results from this study highlight a lower genetic detection rate for Black patients than for White patients with IRDs. This supports a concern that the current development of IRD therapeutics is highly dependent on the ability to identify the genetic cause of disease. Patients with no known genetic diagnosis may be disadvantaged in terms of prognostication, inheritance counseling, reproductive decision-making, and eligibility for potential therapeutic options, including clinical trials. As future treatments become available, these findings suggest the need to examine the genetic detection rates across majority and minority subgroups alike.

JAMA OphthalmologyVol. 142(12)
National Institutes of Health (US), Universidade de São Paulo (BR), University of Michigan (US), Foundation Fighting Blindness (US), Blueprint Genetics (Finland) (FI), National Eye Institute (US)
Reduced inequalities
Openalex Percentile: Top 14%
Retinal Development and Disorders
1.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.